Clinical Trial Update: A Long-Term Trial Investigating Safety and Efficacy of TransCon hGH in Children With Growth Hormone Deficiency Who Have Completed a Prior TransCon hGH Clinical Trial [Phase 3]

View source ↗

Summary

A long-term Phase 3 trial evaluating the safety and efficacy of TransCon hGH in children with growth hormone deficiency who completed a prior TransCon hGH trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Pituitary Diseases

Drugs mentioned

• TransCon hGH (somatropin)

Snippet

Sponsor: Ascendis Pharma A/S | Conditions: Growth Hormone Deficiency, Pediatric, Endocrine System Diseases | Phase 3 | Status: COMPLETED | Results posted: 2024-05-08